Literature DB >> 22072149

Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer.

Noriyoshi Sawabata1, Hajime Maeda, Akihide Matsumura, Mitsunori Ohta, Meinoshin Okumura.   

Abstract

PURPOSE: A pulmonary wedge resection is useful for the treatment of peripheral non-small cell lung cancer (NSCLC). The margin/tumor size ratio (M/T) is a predictor of positive margin cytology findings in these procedures, although the long-term clinical implications remain unclear. This relationship was investigated in this study.
METHODS: Thirty-seven cases with a high surgical risk without additional pulmonary resection were selected from those accrued in a multicenter prospective study of optimal margin distance for pulmonary excision of peripheral NSCLC and followed for more than 5 years (range 5.3-14 years).
RESULTS: Both the M/T and margin cytology findings were indicators of cancer recurrence and survival. All seven cases of surgical margin recurrence had a cytology-positive surgical margin. The 5-year survival rate was 54.2% (n = 24) for M/T < 1 and 84.6% for M/T ≥ 1 (n = 13, P = 0.05), while it was 38.5% for positive margin (n = 13) and 79.2% for negative margin (n = 24) cases (P = 0.001). In addition, the margin cytology findings were an independent prognostic factor.
CONCLUSION: A pulmonary wedge resection for peripheral NSCLC should result in a negative malignant margin, which might be obtained from a sufficient tumor margin ratio of M/T ≥ 1.

Entities:  

Mesh:

Year:  2011        PMID: 22072149     DOI: 10.1007/s00595-011-0031-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  22 in total

1.  Cytologic examination of surgical margin of excised malignant pulmonary tumor: methods and early results.

Authors:  N Sawabata; T Mori; K Iuchi; H Maeda; M Ohta; O Kuwahara
Journal:  J Thorac Cardiovasc Surg       Date:  1999-03       Impact factor: 5.209

2.  Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer.

Authors:  Brett G Masasyesva; Betty C Tong; Malcolm V Brock; Thomas Pilkington; David Goldenberg; David Sidransky; Susan Harden; William H Westra; Joseph Califano
Journal:  Int J Cancer       Date:  2005-03-01       Impact factor: 7.396

3.  Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.

Authors:  Matthew J Schuchert; Brian L Pettiford; Samuel Keeley; Thomas A D'Amato; Arman Kilic; John Close; Arjun Pennathur; Ricardo Santos; Hiran C Fernando; James R Landreneau; James D Luketich; Rodney J Landreneau
Journal:  Ann Thorac Surg       Date:  2007-09       Impact factor: 4.330

4.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

5.  Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study.

Authors:  K Kodama; O Doi; M Higashiyama; H Yokouchi
Journal:  J Thorac Cardiovasc Surg       Date:  1997-09       Impact factor: 5.209

Review 6.  Small peripheral lung adenocarcinoma: clinicopathological features and surgical treatment.

Authors:  Takayuki Fukui; Tetsuya Mitsudomi
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

7.  Prospective study of extended segmentectomy for small lung tumors: the final report.

Authors:  Koichi Yoshikawa; Noriaki Tsubota; Ken Kodama; Hiroyoshi Ayabe; Toshihiko Taki; Takashi Mori
Journal:  Ann Thorac Surg       Date:  2002-04       Impact factor: 4.330

8.  Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.

Authors:  Amgad El-Sherif; William E Gooding; Ricardo Santos; Brian Pettiford; Peter F Ferson; Hiran C Fernando; Susan J Urda; James D Luketich; Rodney J Landreneau
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

9.  Video-assisted thoracic surgical resection of malignant lung tumors.

Authors:  R J Lewis; R J Caccavale; G E Sisler; J W Mackenzie
Journal:  J Thorac Cardiovasc Surg       Date:  1992-12       Impact factor: 5.209

Review 10.  Segmental resection spares pulmonary function in patients with stage I lung cancer.

Authors:  Robert J Keenan; Rodney J Landreneau; Richard H Maley; Deepak Singh; Robin Macherey; Susan Bartley; Tibetha Santucci
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

View more
  22 in total

1.  Multicenter prospective study of sublobar resection for c-stage I non-small cell lung cancer patients unable to undergo lobectomy (KLSG-0801): complete republication.

Authors:  Nobumasa Takahashi; Noriyoshi Sawabata; Masafumi Kawamura; Takashi Ohtsuka; Hirotoshi Horio; Hirozou Sakaguchi; Mitsuo Nakayama; Katsuo Yoshiya; Masayuki Chida; Eishin Hoshi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-05-27

Review 2.  Locoregional recurrence after pulmonary sublobar resection of non-small cell lung cancer: can it be reduced by considering cancer cells at the surgical margin?

Authors:  Noriyoshi Sawabata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-09-29

3.  Tumor spread through air space, the clinical implications for T factor and effects on the disease recurrence and prognosis.

Authors:  Takahiro Nakajima; Junichi Morimoto; Ichiro Yoshino
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

4.  The role of sublobar resections in the treatment of early stage non-small cell lung cancer-still awaiting evidence.

Authors:  Robert Dziedzic
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

5.  Circulating tumor cells in lung cancer: cluster circulating tumor cells as hybrid epithelial-mesenchymal transition/mesenchymal-epithelial transition (E/M).

Authors:  Noriyoshi Sawabata
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

6.  Validating margin status in lung wedge resection for clinical stage I non-small cell lung cancer.

Authors:  Noriyoshi Sawabata; Akikazu Kawase; Nobumasa Takahashi; Takeshi Kawaguchi; Tetsukan Woo; Yuichi Saito; Satoshi Shiono; Noriyuki Matsutani
Journal:  Surg Today       Date:  2018-06-19       Impact factor: 2.549

Review 7.  Adjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC).

Authors:  Bojan Zaric; Vladimir Stojsic; Aleksandar Tepavac; Tatjana Sarcev; Paul Zarogoulidis; Kaid Darwiche; Kosmas Tsakiridis; Ilias Karapantzos; Georgios Kesisis; Ioanna Kougioumtzi; Nikolaos Katsikogiannis; Nikolaos Machairiotis; Aikaterini Stylianaki; Christophoros N Foroulis; Konstantinos Zarogoulidis; Branislav Perin
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

8.  Delivery of eupenifeldin via polymer-coated surgical buttresses prevents local lung cancer recurrence.

Authors:  Zeinab Y Al Subeh; Ngoc-Quynh Chu; Jeremy T Korunes-Miller; Lillian L Tsai; Tyler N Graf; Yin P Hung; Cedric J Pearce; Mark W Grinstaff; Aaron H Colby; Yolonda L Colson; Nicholas H Oberlies
Journal:  J Control Release       Date:  2021-01-21       Impact factor: 9.776

9.  Differential outcomes of residual disease in surgically-resected non-small cell lung cancer and the importance of guideline-concordant adjuvant therapy.

Authors:  Dustin K Lieu; Li Ding; Elizabeth A David; Sean C Wightman; Scott M Atay; P Michael McFadden; Anthony W Kim
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 3.005

10.  The surgical management of early-stage lung adenocarcinoma: is wedge resection effective?

Authors:  Ying Ji; Guangyu Bai; Bin Qiu; Liang Zhao; Jing Zhou; Qi Xue; Shugeng Gao
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.